Preface

Fatty liver disease has become a serious public health problem due to the rise in instances of obesity, diabetes, and associated metabolic diseases worldwide. Effective therapy remains difficult to achieve, even as advances in medical science have improved diagnosis and management. Numerous current treatments have drawbacks, including low medication absorption, insufficient liver tissue targeting, and unfavorable side effects. These difficulties highlight the need for creative therapeutic approaches.

With benefits, such as improved drug absorption, site-specific distribution, and reduced systemic toxicity, nanocarrier-based drug delivery systems have become a viable alternative. These technologies offer the opportunity to improve treatment outcomes for individuals with fatty liver disease by addressing the drawbacks of traditional approaches.

This book offers a thorough analysis of nanocarrier technologies and their potential for treating fatty liver disease. It provides readers with a comprehensive understanding of the potential impact of nanotechnology in this field by examining key concepts, therapeutic applications, and current research. The material bridges the gap between theoretical understanding and real-world application, covering everything from fundamental scientific concepts to the latest developments.

The book is intended as a useful resource for medical researchers, healthcare practitioners, and those in the pharmaceutical sector. It supports upcoming research projects in the field of drug delivery systems, fosters multidisciplinary collaboration, and stimulates new ideas.

We express our heartfelt gratitude to all of the writers and specialists who gave their time and expertise to this collection. In addition to offering clarification and direction, we hope that our work encourages further research and development in the management of fatty liver disease.